Search results for:
belimumab
belimumab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Belimumab |
POWDER FOR INJECTION, INTRAVENOUS |
120 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Belimumab |
POWDER FOR INJECTION, INTRAVENOUS |
400 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Mar. 1, 2024
UNC Health
System Formulary Restriction:
Inpatient use of belimumab is restricted to new starts (ie, not continuation of therapy) for patients with active lupus nephritis. All other use (including continuation of therapy) is restricted to outpatient/clinic use only.
System IV Compounding Compendium Guideline
Med Center
UNC Medical Center Formulary Restrictions